FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465375521> ?p ?o ?g. }

• W2465375521 endingPage "12" @default.
• W2465375521 startingPage "1" @default.
• W2465375521 abstract "Intra-articular injection of hyaluronic acid (HA) for knee osteoarthritis (OA) effectively reduces pain and delays total knee replacement (TKR) surgery; however, little is known about relative differences in clinical and cost outcomes among different HA products.To compare disease-specific costs and risk of TKR among patients receiving different HA treatments in a commercially insured cohort of patients with knee OA in the USA.Retrospective analyses using IMS Health's PharMetrics Plus Health Plan Claims Database were conducted by identifying knee OA patients with claims indicating initiation of HA treatment at an 'index date' during the selection period (2007-2010). Patients were required to be continuously enrolled in the database for 12 months preindex to 36 months postindex. A generalized linear model (GLM) with a gamma distribution and log-link function was used to model aggregate patient-based changes in disease-specific costs. A Cox proportional hazards model (PHM) was used to model the risk of TKR. Both multivariate models included covariates such as age, gender, comorbidities, and preindex healthcare costs.50,389 patients with HA treatment for knee OA were identified. 18,217 (36.2%) patients were treated with HA products indicated for five injections per treatment course (Supartz and Hyalgan). The remainder were treated with HA products indicated for fewer than five injections per treatment course, with 20,518 patients (40.7%) receiving Synvisc; 6,263 (12.4%), Euflexxa; and 5,391 (10.7%), Orthovisc. Synvisc- and Orthovisc-injected patients had greater disease-specific costs compared to Supartz/Hyalgan (9.0%, p<0.0001 and 6.8%, p=0.0050, respectively). Hazard ratios (HRs) showed a significantly higher risk of TKR for patients receiving Synvisc compared to Supartz/Hyalgan (HR=1.069, p=0.0009). Patients treated with Supartz/Hyalgan, Euflexxa, and Orthovisc had longer delays to TKR than those treated with Synvisc.Analysis of administrative claims data provides real-world evidence that meaningful differences exist among some HA products in disease-specific cost and time to knee replacement surgery." @default.
• W2465375521 created "2016-07-22" @default.
• W2465375521 creator A5003368771 @default.
• W2465375521 creator A5011077808 @default.
• W2465375521 creator A5012376116 @default.
• W2465375521 creator A5065153199 @default.
• W2465375521 creator A5070378270 @default.
• W2465375521 date "2016-06-23" @default.
• W2465375521 modified "2023-09-28" @default.
• W2465375521 title "Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database" @default.
• W2465375521 cites W1801646010 @default.
• W2465375521 cites W1831989259 @default.
• W2465375521 cites W1964107962 @default.
• W2465375521 cites W1964189028 @default.
• W2465375521 cites W1985371083 @default.
• W2465375521 cites W1990440127 @default.
• W2465375521 cites W2002348026 @default.
• W2465375521 cites W2011258258 @default.
• W2465375521 cites W2036292654 @default.
• W2465375521 cites W2036491373 @default.
• W2465375521 cites W2039402286 @default.
• W2465375521 cites W2062024856 @default.
• W2465375521 cites W2074311922 @default.
• W2465375521 cites W2100142761 @default.
• W2465375521 cites W2104033333 @default.
• W2465375521 cites W2109443157 @default.
• W2465375521 cites W2111068863 @default.
• W2465375521 cites W2117886820 @default.
• W2465375521 cites W2125118995 @default.
• W2465375521 cites W2129281457 @default.
• W2465375521 cites W2145752025 @default.
• W2465375521 cites W2155484807 @default.
• W2465375521 cites W2157344438 @default.
• W2465375521 cites W2161736885 @default.
• W2465375521 cites W2188671405 @default.
• W2465375521 cites W2210874914 @default.
• W2465375521 cites W2215687845 @default.
• W2465375521 cites W2217484328 @default.
• W2465375521 cites W2281185096 @default.
• W2465375521 cites W2286191622 @default.
• W2465375521 cites W2323019868 @default.
• W2465375521 cites W2395372627 @default.
• W2465375521 cites W2418161203 @default.
• W2465375521 cites W2885849893 @default.
• W2465375521 doi "https://doi.org/10.7573/dic.212296" @default.
• W2465375521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4924978" @default.
• W2465375521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27403194" @default.
• W2465375521 hasPublicationYear "2016" @default.
• W2465375521 type Work @default.
• W2465375521 sameAs 2465375521 @default.
• W2465375521 citedByCount "18" @default.
• W2465375521 countsByYear W24653755212017 @default.
• W2465375521 countsByYear W24653755212018 @default.
• W2465375521 countsByYear W24653755212020 @default.
• W2465375521 countsByYear W24653755212021 @default.
• W2465375521 countsByYear W24653755212022 @default.
• W2465375521 countsByYear W24653755212023 @default.
• W2465375521 crossrefType "journal-article" @default.
• W2465375521 hasAuthorship W2465375521A5003368771 @default.
• W2465375521 hasAuthorship W2465375521A5011077808 @default.
• W2465375521 hasAuthorship W2465375521A5012376116 @default.
• W2465375521 hasAuthorship W2465375521A5065153199 @default.
• W2465375521 hasAuthorship W2465375521A5070378270 @default.
• W2465375521 hasBestOaLocation W24653755211 @default.
• W2465375521 hasConcept C126322002 @default.
• W2465375521 hasConcept C141071460 @default.
• W2465375521 hasConcept C142724271 @default.
• W2465375521 hasConcept C160735492 @default.
• W2465375521 hasConcept C162324750 @default.
• W2465375521 hasConcept C167135981 @default.
• W2465375521 hasConcept C1862650 @default.
• W2465375521 hasConcept C194828623 @default.
• W2465375521 hasConcept C201903717 @default.
• W2465375521 hasConcept C204787440 @default.
• W2465375521 hasConcept C2776164576 @default.
• W2465375521 hasConcept C2778104916 @default.
• W2465375521 hasConcept C2778336525 @default.
• W2465375521 hasConcept C2909830753 @default.
• W2465375521 hasConcept C2992755240 @default.
• W2465375521 hasConcept C3019843197 @default.
• W2465375521 hasConcept C41008148 @default.
• W2465375521 hasConcept C50382708 @default.
• W2465375521 hasConcept C50522688 @default.
• W2465375521 hasConcept C71924100 @default.
• W2465375521 hasConcept C72563966 @default.
• W2465375521 hasConcept C77088390 @default.
• W2465375521 hasConceptScore W2465375521C126322002 @default.
• W2465375521 hasConceptScore W2465375521C141071460 @default.
• W2465375521 hasConceptScore W2465375521C142724271 @default.
• W2465375521 hasConceptScore W2465375521C160735492 @default.
• W2465375521 hasConceptScore W2465375521C162324750 @default.
• W2465375521 hasConceptScore W2465375521C167135981 @default.
• W2465375521 hasConceptScore W2465375521C1862650 @default.
• W2465375521 hasConceptScore W2465375521C194828623 @default.
• W2465375521 hasConceptScore W2465375521C201903717 @default.
• W2465375521 hasConceptScore W2465375521C204787440 @default.
• W2465375521 hasConceptScore W2465375521C2776164576 @default.
• W2465375521 hasConceptScore W2465375521C2778104916 @default.

• next